AR

Andrew Reardon

Chief Legal Officer at Ligand Pharmaceuticals

Prior to joining Ligand, Mr. Reardon was with HealthCare Royalty Management, a manager of investment funds investing in biopharmaceutical products primarily through royalty purchases and structured credit. Prior to HealthCare Royalty Management, Mr. Reardon was an associate with the international law firm Willkie Farr & Gallagher, where he focused on corporate transactions, including finance and mergers and acquisitions. Mr. Reardon earned his J.D. from the University of Iowa College of Law, graduating with High Distinction and receiving the Alan I. Widiss Faculty Scholar Award, and received his B.A. with honors from the State University of New York College at Old Westbury.

Links

Previous companies

Willkie Farr & Gallagher LLP logo
Citigroup logo
HealthCare Royalty logo

Timeline

  • Chief Legal Officer

    November, 2022 - present

View in org chart